Bostel is a clinical-stage biotech company working to leverage the latest developments in Artificial Intelligence and Machine Learning to improve the speed and accuracy of skin cancer diagnosis. Through a novel system incorporating two Deep Learning modules and a proprietary Sonification (translating images into sound) platform, Bostel has developed a highly accurate skin cancer diagnostic. The utility of this system has been successfully demonstrated under real-world conditions, and we are currently working to push the platform to market.